Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Insider Profile

Nash Marc

Officer | SEC CIK: 0001983815

Comprehensive Trading Performance Summary

The investment footprint of Nash Marc as disclosed via official SEC Form 4 filings provides a critical window into professional capital allocation strategies. By tracking this specific portfolio, investors can analyze how this individual moves capital across different boards and sectors. High-conviction moves by key stakeholders often serve as leading indicators for future market performance, as they reflect the intimate operational knowledge and fiduciary confidence of those closest to the company's decision-making process. Monitoring these strategic accumulation or exit patterns helps bridge the gap between institutional boardrooms and the retail investment community.

Filing Date Trade Date Ticker Company Name Industry Relationship Type Price Qty Total, $ Owned After Change, %
2026-02-20 04:56 2026-02-17 OM Outset Medical, Inc. Electromedical & Electrotherapeutic Apparatus Officer - EVP Operations R&D & Service SELL $3.35 1,817 $6,087 39,988 -4.3%
2026-01-22 03:07 2026-01-20 OM Outset Medical, Inc. Electromedical & Electrotherapeutic Apparatus Officer - EVP Operations R&D & Service SELL $5.10 6,355 $32,400 41,805 -13.2%
2026-01-09 01:10 2026-01-07 OM Outset Medical, Inc. Electromedical & Electrotherapeutic Apparatus Officer - EVP Operations R&D & Service SELL $4.27 108 $461 48,160 -0.2%
2025-11-19 00:33 2025-11-17 OM Outset Medical, Inc. Electromedical & Electrotherapeutic Apparatus Officer - EVP Operations R&D & Service SELL $4.60 247 $1,136 48,268 -0.5%
2025-08-18 23:01 2025-08-15 OM Outset Medical, Inc. Electromedical & Electrotherapeutic Apparatus Officer - SVP Operations and R&D SELL $12.88 243 $3,130 42,898 -0.6%
2025-05-17 00:22 2025-05-15 OM Outset Medical, Inc. Electromedical & Electrotherapeutic Apparatus Officer - SVP Operations and R&D SELL $17.82 252 $4,491 13,465 -1.8%
2025-02-20 00:29 2025-02-18 OM Outset Medical, Inc. Electromedical & Electrotherapeutic Apparatus Officer - SVP Operations and R&D SELL $0.90 4,204 $3,784 200,764 -2.1%
2025-01-23 02:04 2025-01-21 OM Outset Medical, Inc. Electromedical & Electrotherapeutic Apparatus Officer - SVP Operations and R&D SELL $0.80 23,221 $18,577 204,968 -10.2%
2025-01-14 02:36 2025-01-13 OM Outset Medical, Inc. Electromedical & Electrotherapeutic Apparatus Officer - SVP Operations and R&D SELL $0.81 15,011 $12,159 222,291 -6.3%
2025-01-08 03:28 2025-01-07 OM Outset Medical, Inc. Electromedical & Electrotherapeutic Apparatus Officer - SVP Operations and R&D SELL $1.29 720 $929 237,302 -0.3%
2024-11-19 01:48 2024-11-15 OM Outset Medical, Inc. Electromedical & Electrotherapeutic Apparatus Officer - SVP Operations and R&D SELL $0.80 1,375 $1,100 238,022 -0.6%
2024-08-16 03:01 2024-08-15 OM Outset Medical, Inc. Electromedical & Electrotherapeutic Apparatus Officer - SVP Operations and R&D SELL $0.84 1,293 $1,086 239,397 -0.5%
2024-07-25 02:08 2024-07-24 OM Outset Medical, Inc. Electromedical & Electrotherapeutic Apparatus Officer - SVP Operations and R&D SELL $4.02 723 $2,906 240,690 -0.3%
2024-05-18 00:38 2024-05-16 OM Outset Medical, Inc. Electromedical & Electrotherapeutic Apparatus Officer - SVP Operations and R&D SELL $3.53 1,097 $3,872 241,413 -0.5%
2024-03-16 01:40 2024-03-15 OM Outset Medical, Inc. Electromedical & Electrotherapeutic Apparatus Officer - SVP Operations and R&D SELL $2.13 2,391 $5,093 242,510 -1.0%
2024-02-17 01:27 2024-02-15 OM Outset Medical, Inc. Electromedical & Electrotherapeutic Apparatus Officer - SVP Operations and R&D SELL $3.57 617 $2,203 243,100 -0.3%
2024-01-18 04:01 2024-01-16 OM Outset Medical, Inc. Electromedical & Electrotherapeutic Apparatus Officer - SVP Operations and R&D SELL $429.00 678 $290,862 243,717 -0.3%
2023-11-18 00:15 2023-11-16 OM Outset Medical, Inc. Electromedical & Electrotherapeutic Apparatus Officer - SVP Operations and R&D SELL $4.76 562 $2,675 44,757 -1.2%
2023-08-17 23:34 2023-08-16 OM Outset Medical, Inc. Electromedical & Electrotherapeutic Apparatus Officer - SVP Operations and R&D SELL $15.10 535 $8,079 44,998 -1.2%
SHOW ENTRIES

Tracking Multi-Role Insiders: Nash Marc

High-level stakeholders like Nash Marc, whether acting as directors, officers, or 10% owners, often possess unique cross-sector insights. Monitoring a specific CIK like 0001983815 allows investors to identify recurring patterns of trading success across various industries. When a large 10% shareholder or a key beneficial owner moves capital, it often signals a strategic shift in institutional or private conviction.

SEC Transparency for Key Stakeholders

Every market move made by Nash Marc is a matter of public record under federal law. By aggregating Form 4 filings, we provide transparency into the portfolios of major players who hold significant influence. Following the money of those with a 10% stake or executive power helps bridge the information gap between the boardroom and the retail investor.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.